Free Trial
OTCMKTS:IPHYF

Innate Pharma (IPHYF) Stock Price, News & Analysis

Innate Pharma logo
$2.06 0.00 (0.00%)
As of 08/29/2025

About Innate Pharma Stock (OTCMKTS:IPHYF)

Key Stats

Today's Range
$2.06
$2.06
50-Day Range
$1.31
$2.06
52-Week Range
$1.31
$2.06
Volume
N/A
Average Volume
15 shs
Market Capitalization
$172.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Innate Pharma Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
4th Percentile Overall Score

IPHYF MarketRank™: 

Innate Pharma scored higher than 4% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Innate Pharma.

  • Percentage of Shares Shorted

    0.00% of the float of Innate Pharma has been sold short.
  • Short Interest Ratio / Days to Cover

    Innate Pharma has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • Dividend Yield

    Innate Pharma does not currently pay a dividend.

  • Dividend Growth

    Innate Pharma does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.00% of the float of Innate Pharma has been sold short.
  • Short Interest Ratio / Days to Cover

    Innate Pharma has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Innate Pharma this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Innate Pharma insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    31.89% of the stock of Innate Pharma is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Innate Pharma's insider trading history.
Receive IPHYF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Innate Pharma and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IPHYF Stock News Headlines

Leaked Gov’t Memo Reveals $100 Trillion Deadline
Only Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, and the deadline is fast-approaching. A new federal plan could legally unlock $100 trillion in U.S. resources... and one $10 stock could lead the charge. Former hedge fund manager Whitney Tilson explains how to act now, before this hits the headlines.tc pixel
Innate Pharma S.A. (IPHYF) - Yahoo Finance
Innate Pharma announces EUR 15M capital increase from Sanofi
See More Headlines

IPHYF Stock Analysis - Frequently Asked Questions

Innate Pharma's stock was trading at $2.90 at the beginning of 2025. Since then, IPHYF stock has decreased by 29.0% and is now trading at $2.0595.

Shares of IPHYF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
9/02/2025
Next Earnings (Estimated)
9/17/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
N/A
Current Symbol
OTCMKTS:IPHYF
Previous Symbol
NASDAQ:IPHYF
CIK
1598599
Employees
179
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.60
Quick Ratio
2.60

Sales & Book Value

Annual Sales
$21.77 million
Price / Sales
7.93
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.11 per share
Price / Book
18.72

Miscellaneous

Outstanding Shares
83,830,000
Free Float
57,097,000
Market Cap
$172.65 million
Optionable
Not Optionable
Beta
0.50

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (OTCMKTS:IPHYF) was last updated on 9/2/2025 by MarketBeat.com Staff
From Our Partners